MYLERAN PRESCRIBING INFORMATION

First Page		Document Content
Date: 2009-03-31 16:04:04 Orphan drugs Busulfan Myeloid leukemia Oncology Chemotherapy Pulmonary toxicity Hematopoietic stem cell transplantation Leukemia Chronic myelogenous leukemia Medicine Chemistry Alkylating antineoplastic agents		MYLERAN PRESCRIBING INFORMATION Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 190,31 KB Share Document on Facebook

	monitoring amiodarone infusion amiodarone walmart. amiodarone halflife. pulmonary mass amiodarone amiodarone hydrochloride amiodarone foxglove poisoning amiodarone pulmonary toxicity risk factors. amiodarone lung disease DocID: 1p3sm - View Document
	Research Article An In Vitro Method for Predicting Inhalation Toxicity of Impregnation Spray Products Jorid B. Sørli 1, Jitka S. Hansen 1, Asger W. Nørgaard 1, Marcus Levin 1,2 and Søren T. Larsen 1 1 DocID: 1ahsq - View Document
	Microsoft Word - SNURMW).docx DocID: 18J2g - View Document
	Microsoft Word - SNURSW).docx DocID: 17yE9 - View Document
	Derivation of occupational exposure levels (OELs) of Low-toxicity isometric biopersistent particles: how can the kinetic lung overload paradigm be used for improved inhalation toxicity study design and OEL-derivation? DocID: 178o0 - View Document